Replies to post #4054 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

> Kamada released a note at TASE that they received a positive review regarding its program to test its inhaled AAT in phase II clinical trials for the treatment of Cystic Fibrosis.<

Good luck with that! Bayer and PPL tried this several years ago but couldn’t make it work (#msg-1603472). Regards, Dew